Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56876 - 56900 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Pantoprazole	Approved Investigational	ABCA1	19	upregulated	pantoprazole results in increased expression of ABCA1 mRNA	9q31.1	A23105
Papaverine	Approved Investigational	HAMP	57817	downregulated	Papaverine results in decreased expression of HAMP mRNA	19q13.12	A20683
Paricalcitol	Approved Investigational	CYP3A4	1576	upregulated	paricalcitol results in increased expression of CYP3A4 mRNA	7q22.1	A22353
Paroxetine	Approved Investigational	PTGS2	5743	downregulated	Paroxetine results in decreased expression of PTGS2 mRNA	1q31.1	A23578
Paroxetine	Approved Investigational	SLC6A4	6532	downregulated	Paroxetine results in decreased expression of SLC6A4 mRNA	17q11.2	A23579
Paroxetine	Approved Investigational	STAT3	6774	downregulated	Paroxetine results in decreased expression of STAT3 mRNA	17q21.2	A23578
Parthenolide	Approved Investigational	BCL2	596	downregulated	parthenolide results in decreased expression of BCL2 mRNA	18q21.33	A23580
Parthenolide	Approved Investigational	CCND1	595	downregulated	parthenolide results in decreased expression of CCND1 mRNA	11q13.3	A23580
Parthenolide	Approved Investigational	CFB	629	downregulated	parthenolide results in decreased expression of CFB mRNA	6p21.33	A23581
Parthenolide	Approved Investigational	DDIT3	1649	upregulated	parthenolide results in increased expression of DDIT3 mRNA	12q13.3	A23582
Parthenolide	Approved Investigational	FAS	355	downregulated	parthenolide results in decreased expression of FAS mRNA	10q23.31	A23583
Parthenolide	Approved Investigational	FASLG	356	downregulated	parthenolide results in decreased expression of FASLG mRNA	1q24.3	A23583
Parthenolide	Approved Investigational	IFNA1	3439	downregulated	parthenolide results in decreased expression of IFNA1 mRNA	9p21.3	A23581
Parthenolide	Approved Investigational	IL12B	3593	downregulated	parthenolide results in decreased expression of IL12B mRNA	5q33.3	A23581
Parthenolide	Approved Investigational	IL1A	3552	downregulated	parthenolide results in decreased expression of IL1A mRNA	2q14.1	A23581
Parthenolide	Approved Investigational	MAPK8	5599	upregulated	parthenolide results in increased expression of MAPK8 mRNA	10q11.22	A23581
Parthenolide	Approved Investigational	MAPK9	5601	upregulated	parthenolide results in increased expression of MAPK9 mRNA	5q35.3	A23581
Parthenolide	Approved Investigational	SAA1	6288	downregulated	parthenolide results in decreased expression of SAA1 mRNA	11p15.1	A23581
Parthenolide	Approved Investigational	SELE	6401	downregulated	parthenolide results in decreased expression of SELE mRNA	1q24.2	A23581
Parthenolide	Approved Investigational	SELP	6403	downregulated	parthenolide results in decreased expression of SELP mRNA	1q24.2	A23581
Parthenolide	Approved Investigational	TLR5	7100	downregulated	parthenolide results in decreased expression of TLR5 mRNA	1q41	A23581
Parthenolide	Approved Investigational	TLR6	10333	downregulated	parthenolide results in decreased expression of TLR6 mRNA	4p14	A23581
Parthenolide	Approved Investigational	TRADD	8717	upregulated	parthenolide results in increased expression of TRADD mRNA	16q22.1	A23581
Parthenolide	Approved Investigational	TRAF1	7185	downregulated	parthenolide results in decreased expression of TRAF1 mRNA	9q33.2	A23581
Parthenolide	Approved Investigational	TRAF2	7186	downregulated	parthenolide results in decreased expression of TRAF2 mRNA	9q34.3	A23581

Displaying entries 56876 - 56900 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability